Target intelligence / Profile preview

Soluble Guanylyl Cyclase (sGC)

Target
sGC
Molecular classification
Enzyme, Hemoprotein
01

Overview

Soluble guanylyl cyclase (sGC) is a cytosolic enzyme that serves as the primary receptor for nitric oxide (NO) in mammalian cells. It is a key mediator of NO signaling, particularly in vascular smooth muscle, where it plays a central role in vasodilation and blood flow regulation. sGC catalyzes the conversion of guanosine triphosphate (GTP) to cyclic guanosine monophosphate (cGMP), an important second messenger involved in various physiological processes. It is a heterodimeric hemoprotein composed of one β1 subunit and either an α1 or α2 subunit. Dysregulation or dysfunction within the NO/sGC/cGMP pathway has been linked to cardiovascular diseases.

Other names
Guanyl cyclaseGuanylyl cyclase
02

Mechanism of action

sGC catalyzes the conversion of guanosine triphosphate (GTP) to cyclic guanosine monophosphate (cGMP), an important second messenger involved in various physiological processes. Binding of NO to the heme moiety increases catalytic activity, rapidly converting GTP into cGMP. cGMP then activates protein kinase G, which phosphorylates downstream targets leading to vasodilation and inhibition of platelet aggregation.

03

Biological functions

Signal transductionVasodilationRegulation of cardiac contractilityModulation of neurotransmissionInhibition of platelet aggregation
04

Disease associations

Cardiovascular diseaseHypertensionHeart failure
05

Safety considerations

Dysfunction or oxidative modification impairs sensitivity toward NO and disrupts vascular function.

Beyond the preview

Go deeper on Soluble Guanylyl Cyclase (sGC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Soluble Guanylyl Cyclase (sGC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call